Cheap, non-invasive tool that detects bowel disease coming in 2027: Hong Kong scientists (South China Morning Post)

Researchers at the Chinese University of Hong Kong have announced a groundbreaking, non-invasive technology that could diagnose inflammatory bowel disease (IBD) using stool samples. Expected to be available in 2027, this innovative method utilizes “droplet digital PCR” to detect bacterial biomarkers associated with IBD, offering faster and more cost-effective results compared to traditional colonoscopy-based diagnostics.